CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation

作者: Chiara Romagnani , Kerstin Juelke , Michela Falco , Barbara Morandi , Antonella D’Agostino

DOI: 10.4049/JIMMUNOL.178.8.4947

关键词:

摘要: Human NK cells can be divided into CD56dimCD16+ killer Ig-like receptors (KIR)+/− and CD56brightCD16− KIR− subsets that have been characterized extensively regarding their different functions, phenotype, tissue localization. Nonetheless, the developmental relationship between these two cell remains controversial. We report that, upon cytokine activation, peripheral blood (PB)-CD56bright mainly gain signature of CD56dim cells. Remarkably, KIR induced not only on CD56bright, but also cells, expression correlates with lower proliferative response. In addition, we demonstrate for first time PB-CD56dim display shorter telomeres than PB- lymph node (LN)-derived CD56bright Along this line, although human collected from nonreactive LN almost no CD16 expression, derived highly reactive LN, efferent lymph, PB express significant amounts CD16, implying could acquire molecules in during inflammation then circulate through as KIR+CD16+ Altogether, our results suggest CD56dimCD16+KIR+/− correspond to sequential steps differentiation support hypothesis secondary lymphoid organs sites final maturation self-tolerance acquisition immune reaction.

参考文章(38)
Nedime Serakinci, Jørn Koch, Detection and sizing of telomeric repeat DNA in situ. Nature Biotechnology. ,vol. 17, pp. 200- 201 ,(1999) , 10.1038/6209
Guido Ferlazzo, Dolca Thomas, Shao-Lee Lin, Kiera Goodman, Barbara Morandi, William A. Muller, Alessandro Moretta, Christian Münz, The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic Journal of Immunology. ,vol. 172, pp. 1455- 1462 ,(2004) , 10.4049/JIMMUNOL.172.3.1455
Sungjin Kim, Koho Iizuka, Hyun-Seok P. Kang, Ayotunde Dokun, Anthony R. French, Suellen Greco, Wayne M. Yokoyama, In vivo developmental stages in murine natural killer cell maturation. Nature Immunology. ,vol. 3, pp. 523- 528 ,(2002) , 10.1038/NI796
Megan A Cooper, Todd A Fehniger, Michael A Caligiuri, The biology of human natural killer-cell subsets. Trends in Immunology. ,vol. 22, pp. 633- 640 ,(2001) , 10.1016/S1471-4906(01)02060-9
Massimo Vitale, Mariella Della Chiesa, Simona Carlomagno, Chiara Romagnani, Andreas Thiel, Lorenzo Moretta, Alessandro Moretta, The small subset of CD56brightCD16– natural killer cells is selectively responsible for both cell proliferation and interferon‐γ production upon interaction with dendritic cells European Journal of Immunology. ,vol. 34, pp. 1715- 1722 ,(2004) , 10.1002/EJI.200425100
Sungjin Kim, Jennifer Poursine-Laurent, Steven M. Truscott, Lonnie Lybarger, Yun-Jeong Song, Liping Yang, Anthony R. French, John B. Sunwoo, Suzanne Lemieux, Ted H. Hansen, Wayne M. Yokoyama, Licensing of natural killer cells by host major histocompatibility complex class I molecules Nature. ,vol. 436, pp. 709- 713 ,(2005) , 10.1038/NATURE03847
Todd A. Fehniger, Eric M. Bluman, Michelle M. Porter, Ewa Mrózek, Megan A. Cooper, Jeffrey B. VanDeusen, Stanley R. Frankel, Wendy Stock, Michael A. Caligiuri, Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy Journal of Clinical Investigation. ,vol. 106, pp. 117- 124 ,(2000) , 10.1172/JCI6218
Aharon G. Freud, Brian Becknell, Sameek Roychowdhury, Hsiaoyin C. Mao, Amy K. Ferketich, Gerard J. Nuovo, Tiffany L. Hughes, Trent B. Marburger, John Sung, Robert A. Baiocchi, Martin Guimond, Michael A. Caligiuri, A Human CD34(+) Subset Resides in Lymph Nodes and Differentiates into CD56brightNatural Killer Cells Immunity. ,vol. 22, pp. 295- 304 ,(2005) , 10.1016/J.IMMUNI.2005.01.013
David H. Raulet, Russell E. Vance, Self-tolerance of natural killer cells Nature Reviews Immunology. ,vol. 6, pp. 520- 531 ,(2006) , 10.1038/NRI1863
Wayne M. Yokoyama, Sungjin Kim, How Do Natural Killer Cells Find Self to Achieve Tolerance? Immunity. ,vol. 24, pp. 249- 257 ,(2006) , 10.1016/J.IMMUNI.2006.03.006